Header image

PARALLEL SESSION 21 - NUTRITION 3

Tracks
TIRANA
Friday, October 24, 2025
9:00 AM - 11:00 AM

Overview

Nutrition and growth


Details

Moderators: Christoph Fusch, Germany and Elena Palleri, Sweden

09.00 - 09.30
Growth in neonates
Mark Johnson, UK

09.30 - 10.00
Biomarkers in clinical nutrition
Miguel Saenz de Pipaon, Spain

10.00 – 10.15 534
Preterm infants at term corrected age have increased total and regional adiposity compared to term born controls Emily Prior (United Kingdom)

10.15 – 10.30 803
Prevention and Management of Metabolic Bone Disease of Prematurity (MBDP): A Systematic Review Eleanor Molloy (Ireland)

10.30 – 10.45 187
A TWO-STAGE FORMULA WITH HUMAN MILK OLIGOSACCHARIDES AND PARTIALLY HYDROLYZED PROTEIN SUPPORTS GROWTH, GASTROINTESTINAL TOLERANCE AND SAFETY OF PRETERM INFANTS: A MULTI-CENTER, OPEN-LABEL, INTERVENTIONAL TRIAL Boutaina Zemrani (Switzerland)

10.45 - 11.00 750
The Gut Microbiome in Preterm Infants with Gastroesophageal Reflux Disease and the Impact of Anti-Reflux Treatment Balpreet Singh (Canada)



Speaker

Prof. Eleanor Molloy
Physician
Trinity College Dublin/chi/coombe Hospitalireland

Prevention and Management of Metabolic Bone Disease of Prematurity (MBDP): A Systematic Review

Dr. Emily Prior
Doctor
Imperial College London

Preterm infants at term corrected age have increased total and regional adiposity compared to term born controls

Dr. Balpreet Singh
Physician
Dalhousie University

The Gut Microbiome in Preterm Infants with Gastroesophageal Reflux Disease and the Impact of Anti-Reflux Treatment

Dr. Boutaina Zemrani
Physician
Société des Produits Nestlé

A TWO-STAGE FORMULA WITH HUMAN MILK OLIGOSACCHARIDES AND PARTIALLY HYDROLYZED PROTEIN SUPPORTS GROWTH, GASTROINTESTINAL TOLERANCE AND SAFETY OF PRETERM INFANTS: A MULTI-CENTER, OPEN-LABEL, INTERVENTIONAL TRIAL

loading